Zhenyang Liu - Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 34 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Efficacy and safety of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil monotherapy for refractory metastatic colorectal cancer: a retrospective cohort study

Rong-Rong Li,Hui-Jun Zhou,De-Yu Zeng,Shao-Feng Jiang,Wu Liu,Petter Frühling,Zhen-Yang Liu

Journal of Gastrointestinal Oncology（2024）

引用0浏览0引用

Fruquintinib with PD-1 Inhibitors Versus TAS-102 with Bevacizumab in Late-Line Mcrc: A Retrospective Cohort Study Based on Propensity Score Matching

Rongrong Li, Xiao-Lin Yang,Zhen-yang Liu,Hui-Jun Zhou,Xian-Li Yin,De-Yu Zeng, Hua Shen, Yi-Dong Zeng,Fang Xiang,Ke Li,Shao-Feng Jiang,Wu Liu

JOURNAL OF CLINICAL ONCOLOGYno. 3_SUPPL (2024): 95-95

引用0浏览0引用

Efficacy and Safety of Trifluridine/tipiracil Plus Bevacizumab Versus Trifluridine/tipiracil Monotherapy for Refractory Metastatic Colorectal Cancer: a Retrospective Cohort Study

Rong-Rong Li,Hui-Jun Zhou, De-Yu Zeng, Shao-Feng Jiang,Wu Liu, Petter Fruehling,Zhen-Yang Liu

Journal of Gastrointestinal Oncologyno. 2 (2024): 612-629

引用0浏览0WOS引用

Correlation Analysis of the Expression of Mesenchymal Circulating Tumor Cells and CD133 with the Prognosis of Colorectal Cancer

Huijun Zhou, Hua Shen,Fang Xiang,Xiaolin Yang,Rongrong Li,Yidong Zeng,Zhenyang Liu

PubMedno. 5 (2023): 3489-3499

引用0浏览0WOS引用

Efficacy and Safety of Trifluridine/tipiracil Plus Bevacizumab Versus Trifluridine/tipiracil Monotherapy for Refractory Metastatic Colorectal Cancer: A Retrospective Study

Rongrong Li,Hui-Jun Zhou,De-Yu Zeng,Shao-Feng Jiang,Wu Liu,Zhen-yang Liu

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Effect of Tumor Exosome-Derived Lnc RNA HOTAIR on the Growth and Metastasis of Gastric Cancer

Pan Chen,Zhenyang Liu,Hua Xiao,Xiaolin Yang,Ting Li,Wei Huang,Huijun Zhou

Clinical & translational oncology（2023）

引用0浏览0WOS引用

Surgical Resection for Second Primary Colorectal Cancer: a Population-Based Study

Ting Li,Zhenyang Liu,Fei Bai,Hua Xiao,Huijun Zhou

Frontiers in medicine (2023)

引用0浏览0WOS引用

A Phase 2 Study of HLX07 As Monotherapy or Combination Therapy in Patients with Locally Advanced, Unresectable, or Metastatic Esophageal Squamous Cell Carcinoma

Jing Huang,Yun Liu,Tao Wu,Zhen-Yang Liu,Jin Zhou, Yuan, Mudan Yang,Bo Liu,Zhenbo Tan,Wu Zhuang,Jiayan Chen,Yanqing Liu,Haoyu Yu,Qingyu Wang,Jun Zhu

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Efficacy, Safety, and Predictors of Fruquintinib Plus Anti-Programmed Death Receptor-1 (PD-1) Antibody in Refractory Microsatellite Stable Metastatic Colorectal Cancer in a Real-World Setting: a Retrospective Cohort Study

Xiaolin Yang,Xianli Yin,Xiaozhou Qu,Geyang Guo,Yidong Zeng,Wu Liu,Mateusz Jagielski,Zhenyang Liu,Huijun Zhou

Journal of gastrointestinal oncologyno. 6 (2023): 2425-2435

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn